Flu, measles, pneumonia and other microbial infections were once easy to treat with antibiotic, antifungal and antiviral drugs. Conditions have become more resistant to drugs, however, the possibility of fatal consequences caused by bacteria, viral, fungal and parasitic infections is increasing. Anti -resistance (AMR) cause 1 million deaths In 2021, a 2024 published according to a report in 2024 Lancet, World health organization Declared in 2023 Amr became a major global health threat,
AMRs can be blamed on many things, including excessive use of antibiotics in people, animals and plants; Inadequate hygiene; And lack of new drugs. Other factors include ineffective prevention measures and lack of new equipment to detect infection.
To discuss how technology can help prevent the spread of AMR, Engineering research vision alliance Last year held a two -day program, attracting over 50 researchers, industry leaders and policy makers. Erva funded by America National science foundationIdentification of areas that address national and global needs, which any aspect that funds research – must consider fasting, government agencies and foundations. The alliance is over 20 Allied partner Involved IEEE,
“Erva is not necessarily a solution to find a solution,” says Anita ShuklaWho presided over 2024 February. “It is about creating long -term research directions that can help reduce problems in long -term, reduce or eradicate problems. We are enabled ideas for research or research.”
Shukla, a professor of engineering Brown universityIn providence, RI, drug delivery, performs research on biomaterials for applications, including treatment of bacteria and fungal infections.
The coalition recently released “Engineering opportunities to combat antimicrobial resistance“The report identified five grand challenges for researchers: diagnostic biosensor and wearballs, engineer antimicrobial surfaces, smart biometrics, cell engineering and advanced modeling approaches.
Biosciences to speed up detection
The report states that rapid, more accurate and less expensive diagnostic tools and wearbals are required to better detect infections. This suggests the development of clinical biosensor, which can detect specific components of pathogens within a sample. According to the report, the biosensor can collect the sample from the patient in a minimum or non -dictatorial manner.
It is the traditional method to find out if someone has an infection, collect samples of their cells, tissue, blood, mucus or other physical fluids and send them to a laboratory for analysis. Depending on the type of infection and testing, it may take a few days to achieve the result.
The alliance suggested the development of diagnostic biosensor that may detect bacteria, viruses, fungi and parasitic pathogens within the sample. The results need to be provided quickly – in a few hours or less, the report states that to reduce the spread of infection, to reduce low recovery time for patients and low health care costs.
But first, research requires research to develop a biosensor that can detect low levels of biomarkers related to infection from the patient’s samples, stated in the report. A biomarker is an average indicator, such as a gene, which can provide information about a person’s health. Currently a person’s immune system may take up to a week up to a week, which can produce enough antibodies to detect a diagnosis.
“I think IEEE members have the right skill set and if they work together to solve this very complex problem with other engineers, they can make a lot of difference.” -Nita Shukla, Engineering Professor at Brown University, Providence, RI
Writers ask engineers, physicians and microbiologists to cooperate to make tools and design them for use in clinical settings.
Progress, reports, can be included in existing smart devices, or new ones can be designed which are infection-specific.
Another area that should be discovered, says, is developing the weedable equipment to allow patients to make themselves accurate diagnosis.
“Engineer, especially electrical engineers who have a lot of knowledge on various biosensor design and wearable technologies, are individuals who need to innovate at this place and produce these techniques,” Shukla.
Cleaner surface to prevent germ spread
In a way, the infection spreads from the bacterial-contaminated surfaces, including hospital beds, medical equipment, dochnobs and desk. No matter how hard the hospital protocols are for sterilization, hygiene and disinfection, bacteria connect to most things. The Erva report states that more than 90 percent curtains used by hospitals for privacy among patients in shared rooms are contaminated after a week.
Authors say that it is mandatory to develop antimicrobial surfaces that can kill bacteria and fungal pathogens on contact. It is also essential materials that release antimicrobial agents when touched including metals, polymers and composites.
New engineer antimicrobial surfaces should be sufficient to face hygiene and sterilization methods used in hospitals and other clinical settings, says Shukla.
Other locations where antimicrobial surfaces should be installed, it says, school and office building.
Clear material to give medicine
According to the report, dressing and other biometric-based drug delivery methods are today used to transport antibiotics directly to a potential infection site, which are not sufficiently advanced to control the amount of drug they released.
The report states that the drug may be excessive use and can increase AMR.
Authors say that the smarter biometric-based delivery system that releases antimicrobial is an essential field of research. Nano- and microscal particles and polymer gels that can only release drugs can be released when a bacterial infection is present, there are some examples quoted in the report.
“These are materials that can release theraputics on demand,” Shukla says. “You highlight the infection to the therapeutic only when it is not required so that you are not introducing much of the drug (more than necessary) -potentially when you can accelerate resistance growth.”
Materials should also contain components that understand the presence of a bacteria or fungus and indicate whether the patient’s immune system is actively fighting infection, the report states. The presence of germs will trigger antibiotic or antifungal to be released at the infection site.
Electrical engineers are an opportunity that they will be included in smart materials to develop those components and will respond to electric fields to help trigger the release of the drug or detect the infection, says Shukla says.
Drug -free cellular engineering
Another area where electrical engineers can play a large role, Shukla says, involve immune cells. According to the report, a potential option for antibiotics, engineer white blood cells can increase the body’s natural reaction to fight infection. Such a drug-free approach will require progress in cellular engineering, however, as well as better understanding of manipulative cells.
For people with frequent infections, it is important to study long -term conversations between engineer immune cells and bacteria, stated in the report. Engineer with antimicrobial activity can help reduce antibiotic use in creating microbes and prevent infection, it says.
Using advanced modeling to develop new drugs
Alliance says that significant research is required to develop computational modeling. Technology can be used to rapidly develop complex bacterial infection models to evaluate the effectiveness of new antimicrobial drugs and therapeutic.
“Modeling has the opportunity to accelerate the development of new drugs and predict the results of potentially new remedies, all in a way that is subject to low expensive and low variability that often occurs with laboratory-based tests,” Shukla says.
AI-based equipment is already used to predict or develop potential medical science, she says, but new algorithms and approaches are still necessary.
“I think IEEE members have the correct skill set and if they work together to solve this very complex problem of AMR, with other engineers, they can make a lot of difference,” Shukla says. “People working in Silos are a problem. If we can work together to deal with this problem, it is how AMR is being resolved.”
You can discuss the findings of the visioning event to Shukla This webinarBuilt on 27 March.
From your site articles
Related articles around web